Molecule Details
InChIKeyZPUCINDJVBIVPJ-LJISPDSOSA-N
Compound NameCocaine
Canonical SMILESCOC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Cross-Family
Avg pChEMBL6.95
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00907
Drug NameCocaine
CAS Number50-36-2
Groups approved illicit investigational
ATC Codes S01HA01 S02DA02 N01BC01 R02AD03
DescriptionAn alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of...

Categories: Agents producing tachycardia Agents that reduce seizure threshold Alkaloids Analgesics and Anesthetics Anesthetics Anesthetics, Local Anticholinergic Agents Aza Compounds Azabicyclo Compounds Cardiovascular Agents Central Nervous System Agents Central Nervous System Stimulants Cholinesterase substrates Cocaine, antagonists & inhibitors Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dopamine Agents Dopamine Uptake Inhibitors Esters of Benzoic Acid Highest Risk QTc-Prolonging Agents Local Anesthetics (Ester) Membrane Transport Modulators Muscarinic Antagonists Nervous System Neurotransmitter Agents Neurotransmitter Uptake Inhibitors OCT2 Inhibitors Ophthalmologicals QTc Prolonging Agents Sensory Organs Sensory System Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Throat Preparations Tropanes Vasoconstrictor Agents
Cross-references: BindingDB: 86207 ChEBI: 27958 CHEMBL370805 ChemSpider: 10194104 Drugs Product Database (DPD): 20241 Guide to Pharmacology: 2286 IUPHAR: 2286 C01416 D00110 PDB: COC PharmGKB: PA449072 PubChem:446220 PubChem:46506326 RxCUI: 2653 Therapeutic Targets Database: DAP000834 Wikipedia: Cocaine ZINC: ZINC000003875336
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
Q12809 KCNH2 Homo sapiens Human PF00027 PF00520 PF13426 8.4 IC50 ChEMBL
Q01959 SLC6A3 Homo sapiens Human PF00209 6.5 Ki ChEMBL;BindingDB
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 6.5 Ki ChEMBL;BindingDB
P23975 SLC6A2 Homo sapiens Human PF00209 6.4 IC50 ChEMBL;BindingDB
DrugBank Target Actions (16)
Target Gene Target Name Action Type
P02763 P02763 alpha1-acid glycoprotein binder carriers
P10632 CYP2C8 Cytochrome P450 2C8 downregulator enzymes
P10635 CYP2D6 Cytochrome P450 2D6 inhibitor enzymes
P06276 BCHE Cholinesterase substrate enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P23141 CES1 Liver carboxylesterase 1 substrate enzymes
Q99720 SIGMAR1 Sigma non-opioid intracellular receptor 1 agonist targets
P08172 CHRM2 Muscarinic acetylcholine receptor M2 antagonist targets
P11229 CHRM1 Muscarinic acetylcholine receptor M1 antagonist targets
P23141 CES1 Liver carboxylesterase 1 binder targets
P23975 SLC6A2 Sodium-dependent noradrenaline transporter inhibitor targets
P31645 SLC6A4 Sodium-dependent serotonin transporter inhibitor targets
P35498 SCN1A Sodium channel protein inhibitor targets
Q01959 SLC6A3 Sodium-dependent dopamine transporter inhibitor targets
O15244 SLC22A2 Solute carrier family 22 member 2 inhibitor transporters
Q01959 SLC6A3 Sodium-dependent dopamine transporter inhibitor transporters